These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The antiemetic efficacy of oral ondansetron plus intravenous dexamethasone in patients with gynecologic malignancies receiving carboplatin-based chemotherapy. Markman M; Kennedy A; Webster K; Peterson G; Kulp B; Belinson J Gynecol Oncol; 2000 Jul; 78(1):43-6. PubMed ID: 10873408 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy. Chiou TJ; Tzeng WF; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429 [TBL] [Abstract][Full Text] [Related]
4. Control of carboplatin-induced emesis with a fixed low dose of granisetron (0.5 mg) plus dexamethasone. Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J Gynecol Oncol; 1996 Mar; 60(3):435-7. PubMed ID: 8774653 [TBL] [Abstract][Full Text] [Related]
5. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma. Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311 [TBL] [Abstract][Full Text] [Related]
6. A randomized trial of once vs twice daily administration of intravenous granisetron with dexamethosone in patients receiving high-dose cyclophosphamide, thiotepa and carboplatin. Birch R; Weaver CH; Carson K; Buckner CD Bone Marrow Transplant; 1998 Oct; 22(7):685-8. PubMed ID: 9818697 [TBL] [Abstract][Full Text] [Related]
7. [A randomized cross-over comparative study of granisetron alone and combination of granisetron, methylprednisolone and droperidol as antiemetic prophilaxis in CDDP-based chemotherapy for gynecologic cancer]. Wataba K; Sagae S; Fukunaka N; Sugimura M; Akutagawa N; Hayashi T; Yamana K; Nakamura T; Terasawa K; Mizumoto H; Kitajima Y; Kudo R Gan To Kagaku Ryoho; 1997 Apr; 24(6):691-7. PubMed ID: 9126306 [TBL] [Abstract][Full Text] [Related]
8. An all oral antiemetic regimen for patients undergoing high-dose chemotherapy with peripheral blood stem cell transplant. Frakes LA; Brehm TL; Kosty MP; Miller WE; McMillan RL; Mason J; Meisenberg BR Bone Marrow Transplant; 1997 Sep; 20(6):473-8. PubMed ID: 9313880 [TBL] [Abstract][Full Text] [Related]
9. Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation. Abbott B; Ippoliti C; Bruton J; Neumann J; Whaley R; Champlin R Bone Marrow Transplant; 1999 Feb; 23(3):265-9. PubMed ID: 10084258 [TBL] [Abstract][Full Text] [Related]
10. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis. Sorbe BG; Berglind AM; Andersson H; Boman K; Högberg T; Hallgren M; Schmidt M Cancer; 1998 Sep; 83(5):1022-32. PubMed ID: 9731907 [TBL] [Abstract][Full Text] [Related]
11. Antiemetic efficacy of an oral suspension of granisetron plus dexamethasone and influence of quality of life on risk for nausea and vomiting. Jordan K; Grothey A; Kegel T; Fibich C; Schöbert C Onkologie; 2005 Feb; 28(2):88-92. PubMed ID: 15662112 [TBL] [Abstract][Full Text] [Related]
12. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy. Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140 [TBL] [Abstract][Full Text] [Related]
13. Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting. Hajdenberg J; Grote T; Yee L; Arevalo-Araujo R; Latimer LA J Support Oncol; 2006 Oct; 4(9):467-71. PubMed ID: 17080735 [TBL] [Abstract][Full Text] [Related]
14. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting. Voravud N; Sriuranpong V J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975 [TBL] [Abstract][Full Text] [Related]
15. Comparative crossover trial of two intravenous doses of granisetron (1 mg vs 3 mg) + dexamethasone in the prevention of acute cis-platinum-induced emesis. Martoni A; Piana E; Strocchi E; Angelelli B; Guaraldi M; Zamagni C; Camaggi CM; Pannuti F Anticancer Res; 1998; 18(4B):2799-803. PubMed ID: 9713464 [TBL] [Abstract][Full Text] [Related]
16. Granisetron (Kytril) plus dexamethasone for antiemetic control in bone marrow transplant patients receiving highly emetogenic chemotherapy with or without total body irradiation. Abbott B; Ippoliti C; Hecth D; Bruton J; Whaley B; Champlin R Bone Marrow Transplant; 2000 Jun; 25(12):1279-83. PubMed ID: 10871733 [TBL] [Abstract][Full Text] [Related]
17. A double-blind randomized study comparing intramuscular (i.m.) granisetron with i.m. granisetron plus dexamethasone in the prevention of delayed emesis induced by cisplatin. The Italian Multicenter Study Group. Anticancer Drugs; 1999 Jun; 10(5):465-70. PubMed ID: 10477166 [TBL] [Abstract][Full Text] [Related]
18. Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy. Aksoylar S; Akman SA; Ozgenç F; Kansoy S Pediatr Hematol Oncol; 2001 Sep; 18(6):397-406. PubMed ID: 11554235 [TBL] [Abstract][Full Text] [Related]
19. [Multi-drug antiemetic treatment and effect of treatment duration of concurrent steroids--for complete control of chemotherapy-induced nausea/vomiting in gynecological cancer]. Fujii T; Nakata N; Shiroyama Y; Sawasaki T; Tanimoto H; Shigemasa K; Kioka H; Naito H Gan To Kagaku Ryoho; 1997 Dec; 24(15):2245-52. PubMed ID: 9422069 [TBL] [Abstract][Full Text] [Related]
20. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation. Fox-Geiman MP; Fisher SG; Kiley K; Fletcher-Gonzalez D; Porter N; Stiff P Biol Blood Marrow Transplant; 2001; 7(11):596-603. PubMed ID: 11760147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]